The Wall Street Journal @WSJ
An oral Covid-19 treatment developed by Atea Pharmaceuticals failed in a midstage trial, the company said Tuesday, sending the company’s stock tumbling https://t.co/T12Yb8L34F — PolitiTweet.org
Created
Tue Oct 19 15:30:10 +0000 2021
Likes
27
Retweets
17
Source
SocialFlow
View Raw Data
JSON DataView on Twitter
Likely Available
The Wall Street Journal @WSJ
An oral Covid-19 treatment developed by Atea Pharmaceuticals failed in a midstage trial, the company said Tuesday, sending the company’s stock tumbling https://t.co/T12Yb8L34F — PolitiTweet.org